Tonix Pharmaceuticals Holding Corp (TNXP)
Cost of Revenue
$5.75M
TTM · Period ending: · USD
TNXP Cost of Revenue
Latest reported$5.75Mperiod ending
Latest reported$5.75Mperiod ending
TNXP TTM Cost of Revenue ($0.00 → $5.75M)
TTM cost of revenue
High-resolution chart · PNG
TNXP cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 5,749,000 | |
| 8,318,000 | |
| 7,128,000 | |
| 6,765,000 | |
| 6,953,000 | |
| 7,048,000 | |
| 7,765,000 | |
| 10,440,000 | |
| 11,259,000 | |
| 7,892,000 | |
| 6,232,000 | |
| 2,374,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,891,000 | |
| 13,797,000 | |
| 20,094,000 | |
| 20,094,000 | |
| 17,744,000 | |
| 17,981,000 | |
| 18,672,000 | |
| 39,963,000 | |
| 40,257,000 | |
| 38,936,000 | |
| 37,039,000 | |
| 54,717,000 | |
| 56,491,000 | |
| 61,505,000 | |
| 70,428,000 | |
| 79,621,000 | |
| 85,292,000 | |
| 87,240,000 | |
| 82,922,000 | |
| 62,416,000 | |
| 56,570,000 | |
| 50,835,000 | |
| 46,308,000 | |
| 29,540,000 | |
| 25,197,680 | |
| 21,234,369 | |
| 18,066,594 | |
| 13,840,004 | |
| 12,482,666 | |
| 12,247,916 | |
| 11,407,056 | |
| 8,124,174 | |
| 6,389,832 | |
| 4,538,893 | |
| 3,378,528 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 8,500 | |
| 17,000 | |
| 17,000 | |
| 17,000 | |
| 8,500 | |
| 0 |